Prostate Cancer Researchers Aim to Make Therapy Effective Again in Resistant Patients

Prostate Cancer Researchers Aim to Make Therapy Effective Again in Resistant Patients
A signaling pathway that promotes prostate cancer growth may offer a new therapeutic target for advanced prostate cancer patients, researchers say in a  study titled “Checkpoint Kinase 2 Negatively Regulates Androgen Sensitivity and Prostate Cancer Cell Growth,” and published in the journal Cancer Research. Prostate cancer patients respond to androgen deprivation therapy (ADT) in the early stages of the disease, but later develop

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *